You've wasted no time at all, I think most LTHs are obviously confident but we have no reason not to be. The company is launching a hassle free, no fuss product with a great safety profile... We believe in management to launch it the right way as they have done with many other drugs.
Are there risks? Absolutely, but much less than we had before approval.
Your thoughts are welcome and read by many of us. Cheers
Bot Chart, page-14539
-
- There are more pages in this discussion • 504 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.015(3.90%) |
Mkt cap ! $672.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.603M | 7.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 292539 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 24998 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |